With a deep sequencer, a machine that reads the human genome and its expression, a researcher in Israel is looking at how the genetic expression of small regulatory genes, called microRNAs, affects the way a patient reacts to medication. This could mean fewer deaths from adverse drug effects and novel and safe uses for existing medications.